HYTN Innovations Inc (TSE:HYTN) has released an update.
HYTN Innovations Inc., a leader in developing and manufacturing psychoactive and psychotropic products, has announced its acquisition of Prism Scientific Labs Inc., aiming to enhance its product offerings with Prism’s advanced light spectrum technology for organism growth. This strategic move, marked by the exchange of 12.1 million shares, is set to consolidate HYTN’s position in the market pending regulatory approvals. HYTN continues its mission to become the foremost provider of federally regulated psychoactive products.
For further insights into TSE:HYTN stock, check out TipRanks’ Stock Analysis page.
